| MeSH term | MeSH ID | Detail |
|---|---|---|
| Heart Failure | D006333 | 36 associated lipids |
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Osteolysis | D010014 | 8 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Osteoarthritis, Hip | D015207 | 4 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Middleton K et al. | Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. | 2017 | J Biomech | pmid:28552413 |
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| Lu LY et al. | Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. | 2017 | J. Orthop. Res. | pmid:28248001 |
| Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
| Liu XY et al. | Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. | 2017 | Int. Immunopharmacol. | pmid:28092862 |
| Choi EM et al. | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. | 2017 | Environ. Toxicol. | pmid:28836330 |
| Chen X et al. | Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. | 2017 | Environ. Toxicol. Pharmacol. | pmid:28738286 |
| Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
| Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
| Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
| Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
| Spirlandeli AL et al. | Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. | 2017 | Clinics (Sao Paulo) | pmid:28492723 |
| Liu J et al. | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. | 2017 | PLoS ONE | pmid:28319142 |
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
| Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
| Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
| Yin LL et al. | Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. | 2017 | Eur Rev Med Pharmacol Sci | pmid:28121359 |
| Bondar C et al. | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. | 2017 | Int J Mol Sci | pmid:28098793 |
| Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
| Ji J et al. | Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. | 2017 | J Toxicol Sci | pmid:28070108 |
| Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
| Hygum K et al. | MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. | 2017 | Eur. J. Endocrinol. | pmid:28049653 |
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Yu M et al. | Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. | 2016 Apr-Jun | J Cancer Res Ther | pmid:27461682 |
| Kwon A et al. | Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. | 2016 | Medicine (Baltimore) | pmid:27082605 |
| Hsu BG et al. | Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. | 2016 | Medicine (Baltimore) | pmid:27082570 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
| Kobayashi Y et al. | Regulation of bone metabolism by Wnt signals. | 2016 | J. Biochem. | pmid:26711238 |
| Chen Z et al. | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. | 2016 | Int. J. Mol. Med. | pmid:26677102 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Meijome TE et al. | C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. | 2016 | J. Cell. Biochem. | pmid:26375403 |
| Pietschmann P et al. | Immunology of Osteoporosis: A Mini-Review. | 2016 | Gerontology | pmid:26088283 |
| Ostrowska Z et al. | TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. | 2016 | Endokrynol Pol | pmid:27828689 |
| Kan C et al. | Cancer Cell Colonisation in the Bone Microenvironment. | 2016 | Int J Mol Sci | pmid:27782035 |
| Huang HM et al. | Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. | 2016 | Chin. Med. J. | pmid:27779163 |
| Kamata R et al. | EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. | 2016 | PLoS ONE | pmid:27764222 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| Li B et al. | Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. | 2016 | Int J Mol Sci | pmid:27110777 |